Till date eight cases of the disease have been detected in India, out of which five have foreign travel history, the minister of health and family welfare said.
The total recoveries have surged to 58,27,704 while there are 9,02,425 active cases of coronavirus infection in the country.
"The COVID-19 cases are rising, but hospitalization and deaths are still less," said sources.
The number of people who have recuperated from the disease surged to 1,04,62,631 pushing the national COVID-19 recovery rate of 97.08 per cent, while the COVID-19 case fatality rate stands at 1.43 per cent.
The death toll reached 1,28,668 after 547 more fatalities were reported in the country in a span of 24 hours, the data updated at 8 am showed.
The number of active cases remained below 5 lakh for the second consecutive day.
The number of active cases of COVID-19 remained below 6 lakh for the ninth consecutive day.
The coronavirus caseload surged to 56,46,010, while the death toll climbed to 90,020 with 1,085 people succumbing to the disease in a span of 24 hours, the data updated at 8 am showed.
With this, the total coronavirus cases in the country have risen to 1,06,67,736 including 1,84,182 active cases and 1,03,30,084 total discharges. However, the total death toll in the country due to the infection mounted to 1,53,470 including the new deaths.
A total of 72,01,070 people have recuperated from COVID-19 so far, pushing the national recovery rate to 90.62 per cent while the case fatality rate stands at 1.50 per cent.
The number of total active COVID-19 cases stood at 6,53,717.
The number of people who have recuperated from the disease surged to 1,31,08,582, while the case fatality rate has further dropped to 1.18 per cent, the data stated.
India's apex drug regulator has granted permission for conducting the phase II/III clinical trial of Bharat Biotech's Covaxin COVID-19 vaccine in the age group of 2 to 18 years, the Union Health Ministry said on Thursday.
For six days in a row the active cases of COVID-19 remained below 9 lakh.
For the fifth day in a row, the active cases of COVID-19 remained below 9 lakh.
The COVID-19 active caseload remained below two lakh for the 14th consecutive day.
The death toll has increased to 2,34,083 with 3,915 fatalities being reported in a span of 24 hours, the data updated at 8 am showed.
According to the Indian Council of Medical Research, 7,31,10,041 samples have been tested up to September 28 for COVID-19. Out of these 11,42,811 samples were tested on Monday.
The number of people who have recuperated from the disease surged to 1,45,56,209 while the case fatality rate has further dropped to 1.12 per cent, the data stated.
There are 9,75,861 active cases of the coronavirus infection in the country which comprises 17.54 per cent of the total caseload, the data stated.
The recovery rate was recorded at 76.28 per cent, while the COVID-19 case fatality rate has further declined to 1.82 per cent.
Registering a steady increase for the 34th day in a row, the number of active cases rose to 12,64,698, or 9.24 per cent of the total infections.
Coronavirus cases in India hit a record daily high since the the outbreak of the pandemic with 1,03,558 new infections pushing the nationwide COVID-19 tally to 1,25,89,067, according to the Union health ministry data.
The death toll increased to 1,62,927 with 459 daily new fatalities, the highest in around 116 days.
The phase 3 trial findings indicate that Covaxin induces a robust antibody response with no severe vaccine-related adverse events or deaths reported among the trial participants, the authors of the study said.
With 17,51,555 people defeating the disease, the recovery rate has surged to 71.17 per cent.
The government has ordered monoclonal antibody from Indian Council of Medical Research to treat the child. It is the only available anti-viral treatment for Nipah virus infection, though it has not been clinically proven yet.
The death toll due to COVID-19 climbed to 47,033 with 942 people succumbing to the disease in the last 24 hours, health ministry data updated at 8 am showed.
The Vaccine War leans towards stoking nationalistic fervour, but that shouldn't stop you from watching a film that is solemn about the Indian scientific community's achievement, notes Mayur Sanap.
Training his guns on Modi, he said, '(The) PM is silent. He has surrendered and is refusing to fight the pandemic.'
Niclosamide, a drug on the World Health Organisation's list of essential medicines, has been used to treat tapeworm infestation for more than 50 years. The oral antiviral drug was also used to treat patients during the SARS outbreak of 2003-04.
The COVID-19 active caseload remained below 2 lakh.
The death toll climbed to 5,24,413 with 65 fresh fatalities.
The number of active cases remained below 5 lakh for the fifth consecutive day.
In this exclusive interview with Rediff.com's Shobha Warrier from Jaipur, Dr Gupta talks about the study and what the urban population to do to fight hypertension.
Given the recurring outbreaks in the last five years, the government is considering domestic manufacturing of monoclonal antibodies for treating Nipah virus infections and is in talks with Serum Institute of India, report Shine Jacob and Sohini Das.
The total coronavirus cases mounted to 49,30,236, while the death toll climbed to 80,776 with 1,054 people succumbing to the disease in a span of 24 hours, the data updated at 8 am showed.
There are 9,73,175 active cases of COVID-19 in the country which comprises 20.47 per cent of the total caseload, the data stated.
Lack of sleep, unhealthy eating habits, physical inactivity and a stressful daily schedule stemming from demanding career paths to juggling multiple hats on the personal front are some factors that increase health challenges, especially in young Indians, notes dietician Sheryl Salis.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances